ArticlePloS one2025
AI-Assisted identification of sex-specific patterns in diabetic retinopathy using retinal fundus images.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of Hyperuricemia with the Onset and Progression of Type 2 Diabetic Retinopathy.Journal of clinical medicine · 2026Article
- A panoramic perspective: application prospects and outlook of multimodal artificial intelligence in the management of diabetic retinopathy.Frontiers in public health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a microvascular complication of diabetes that can lead to blindness if left untreated. Regular monitoring is crucial for detecting early signs of referable DR, and the progression to moderate to severe non-proliferative DR, proliferative DR (PDR), and macular edema (ME), the most common cause of vision loss in DR. Currently, aside from considerations during pregnancy, sex is not factored into DR diagnosis, management or treatment. Here we examine whether DR manifests differently in male and female patients, using a dataset of retinal images and leveraging convolutional neural networks (CNN) integrated with explainable artificial intelligence (AI) techniques. To minimize confounding variables, we curated 2,967 fundus images from a larger dataset of DR patients acquired from EyePACS, matching male and female groups for age, ethnicity, severity of DR, and hemoglobin A1C levels. Next, we fine-tuned two pre-trained VGG16 models-one trained on the ImageNet dataset and another on a sex classification task using healthy fundus images-achieving AUC scores of 0.72 and 0.75, respectively, both significantly above chance level. To uncover how these models distinguish between male and female retinas, we used the Guided Grad-CAM technique to generate saliency maps, highlighting critical retinal regions for correct classification. Saliency maps showed CNNs focused on different retinal regions by sex: the macula in females, and the optic disc and peripheral vasculature along the arcades in males. This pattern differed noticeably from the saliency maps generated by CNNs trained on healthy eyes. These findings raise the hypothesis that DR may manifest differently by sex, with women potentially at higher risk for developing ME, as opposed to men who may be at greater risk for PDR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.